The protective effect of Sigmar1 in diabetes-induced retinal neurodegeneration has also been demonstrated using Sigmar1 null mice, where the absence of Sigmar1 aggravated retinal ganglionic cell dysfunction in streptozotocin-injected diabetic mice (Ha et al., 2012). This evidence concerns the gene SIGMAR1 and diabetes mellitus.